Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Malignant Melanoma

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 25 articles: HTML format

Single Articles

February 2023
1. BASSEY-ARCHIBONG BI, Rajendra Chokshi C, Aghaei N, Kieliszek AM, et al
   An HLA-G/SPAG9/STAT3 axis promotes brain metastases.
   Proc Natl Acad Sci U S A. 2023;120:e2205247120.
   PubMed     Abstract available
   
   
   
2. 
   Correction for Dar et al., Bromodomain inhibition overcomes treatment resistance in distinct molecular subtypes of melanoma.
   Proc Natl Acad Sci U S A. 2023;120:e2300251120.
   PubMed    
   
   
   January 2023
3. BANNOUD N, Stupirski JC, Cagnoni AJ, Hockl PF, et al
   Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology.
   Proc Natl Acad Sci U S A. 2023;120:e2214350120.
   PubMed     Abstract available
   
   
   December 2022
4. STOPFER LE, Rettko NJ, Leddy O, Mesfin JM, et al
   MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas.
   Proc Natl Acad Sci U S A. 2022;119:e2208900119.
   PubMed     Abstract available
   
   
   November 2022
5. TOMASINA F, Martinez J, Zeida A, Chiribao ML, et al
   De novo sequencing and construction of a unique antibody for the recognition of alternative conformations of cytochrome c in cells.
   Proc Natl Acad Sci U S A. 2022;119:e2213432119.
   PubMed     Abstract available
   
   
   August 2022
6. DAR AA, Bezrookove V, Nosrati M, Ice R, et al
   Bromodomain inhibition overcomes treatment resistance in distinct molecular subtypes of melanoma.
   Proc Natl Acad Sci U S A. 2022;119:e2206824119.
   PubMed     Abstract available
   
   
   
7. LIU X, Wang Y, Bauer AT, Kirschfink M, et al
   Neutrophils activated by membrane attack complexes increase the permeability of melanoma blood vessels.
   Proc Natl Acad Sci U S A. 2022;119:e2122716119.
   PubMed     Abstract available
   
   
   May 2022
8. PHELPS GB, Hagen HR, Amsterdam A, Lees JA, et al
   MITF deficiency accelerates GNAQ-driven uveal melanoma.
   Proc Natl Acad Sci U S A. 2022;119:e2107006119.
   PubMed     Abstract available
   
   
   March 2022
9. KAVRAN AJ, Stuart SA, Hayashi KR, Basken JM, et al
   Intermittent treatment of BRAF(V600E) melanoma cells delays resistance by adaptive resensitization to drug rechallenge.
   Proc Natl Acad Sci U S A. 2022;119:e2113535119.
   PubMed     Abstract available
   
   
   
10. GUPTA A, Smith P, Bournazos S, Ravetch JV, et al
    A novel mouse strain optimized for chronic human antibody administration.
    Proc Natl Acad Sci U S A. 2022;119:e2123002119.
    PubMed     Abstract available
    
    
    February 2022
11. AURORA AB, Khivansara V, Leach A, Gill JG, et al
    Loss of glucose 6-phosphate dehydrogenase function increases oxidative stress and glutaminolysis in metastasizing melanoma cells.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available
    
    
    January 2022
12. KIM G, Wu Q, Chu JL, Smith EJ, et al
    Ultrasound controlled mechanophore activation in hydrogels for cancer therapy.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available
    
    
    October 2021
13. GANGAEV A, Rozeman EA, Rohaan MW, Isaeva OI, et al
    Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    September 2021
14. STOPFER LE, Gajadhar AS, Patel B, Gallien S, et al
    Absolute quantification of tumor antigens using embedded MHC-I isotopologue calibrants.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    June 2021
15. ZHAO J, Jaffe A, Li H, Lindenbaum O, et al
    Detection of differentially abundant cell subpopulations in scRNA-seq data.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    May 2021
16. YIN Q, Yu W, Grzeskowiak CL, Li J, et al
    Nanoparticle-enabled innate immune stimulation activates endogenous tumor-infiltrating T cells with broad antigen specificities.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    April 2021
17. YIN W, Li Y, Song Y, Zhang J, et al
    CCRL2 promotes antitumor T-cell immunity via amplifying TLR4-mediated immunostimulatory macrophage activation.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
18. FALAHAT R, Berglund A, Putney RM, Perez-Villarroel P, et al
    Epigenetic reprogramming of tumor cell-intrinsic STING function sculpts antigenicity and T cell recognition of melanoma.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    March 2021
19. TENGESDAL IW, Menon DR, Osborne DG, Neff CP, et al
    Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    February 2021
20. ZHANG H, You X, Wang X, Cui L, et al
    Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    December 2020
21. PATUTINA OA, Gaponova Miroshnichenko SK, Sen'kova AV, Savin IA, et al
    Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency.
    Proc Natl Acad Sci U S A. 2020;117:32370-32379.
    PubMed     Abstract available
    
    
    
22. EISINGER S, Sarhan D, Boura VF, Ibarlucea-Benitez I, et al
    Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells.
    Proc Natl Acad Sci U S A. 2020;117:32005-32016.
    PubMed     Abstract available
    
    
    November 2020
23. LU Y, Sandoval A, Voss S, Lai Z, et al
    Oncogenic allelic interaction in Xiphophorus highlights hybrid incompatibility.
    Proc Natl Acad Sci U S A. 2020;117:29786-29794.
    PubMed     Abstract available
    
    
    August 2020
24. LI N, Kang Y, Wang L, Huff S, et al
    ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment.
    Proc Natl Acad Sci U S A. 2020;117:20159-20170.
    PubMed     Abstract available
    
    
    June 2020
25. LEX K, Maia Gil M, Lopes-Bastos B, Figueira M, et al
    Telomere shortening produces an inflammatory environment that increases tumor incidence in zebrafish.
    Proc Natl Acad Sci U S A. 2020;117:15066-15074.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: